Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

By S. Shelburne, F. Visnegarwala, Jorge G Darcourt, E. Graviss, Thomas P. Giordano, A. White, R. Hamill. AIDS (London), 2005

641 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Biophysics, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/17c5de9dbf1a2a2bbd5e37eb3cef65d7a1932692

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. Perfect
2. P. Pappas
3. W. Dismukes
4. F. Dromer
5. D. Goldman
6. R. Hamill
7. G. Meintjes
8. J. Graybill

Citations in the corpus

• Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. (2008, positive): “Median 42 days (range 10–89 days) ·· Shelburne et al (2005)†21 USA 86 26 (30”
• Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America (2010, background): “Cryptococcal antigenemia has been shown to be associated with increased mortality among those initiating HAART, and persons with asymptomatic antigenemia are at theoretical risk of the “unmasking” form of cryptococcal IRIS [67].”